"1826"^^ . . . . . "screeningov\u00E9ho programu"@cs . "Screening"@cs . "Screening"@cs . "plo\u0161n\u00E9ho vy\u0161et\u0159en\u00ED"@cs . "screeningov\u00E9ho vy\u0161et\u0159en\u00ED"@cs . "8"^^ . "12763026"^^ . . "screeningu"@cs . . . . . . "87864"^^ . "Screening je v l\u00E9ka\u0159stv\u00ED vy\u0161et\u0159ov\u00E1n\u00ED p\u0159edem definovan\u00E9 skupiny lid\u00ED za \u00FA\u010Delem vyhled\u00E1v\u00E1n\u00ED chorob v jejich \u010Dasn\u00FDch st\u00E1di\u00EDch, kdy pacient je\u0161t\u011B nem\u00E1 pot\u00ED\u017Ee a p\u0159\u00EDznaky nebo jsou tyto p\u0159\u00EDznaky spolehliv\u011B identifikovateln\u00E9 jen \u010Dasov\u011B nebo finan\u010Dn\u011B n\u00E1kladn\u00FDm procesem. C\u00EDlem screeningu je brzk\u00E9 rozezn\u00E1n\u00ED nemoci v nad\u011Bji, \u017Ee se v\u010Dasn\u00FDm z\u00E1sahem a p\u00E9\u010D\u00ED poda\u0159\u00ED sn\u00ED\u017Eit \u00FAmrtnost a str\u00E1d\u00E1n\u00ED. I kdy\u017E m\u016F\u017Ee screening v\u00E9st k \u010Dasn\u011Bj\u0161\u00ED diagn\u00F3ze, ukazuje se, \u017Ee ne poka\u017Ed\u00E9 testy prosp\u011Bj\u00ED testovan\u00E9 osob\u011B. Nadm\u011Brn\u00E1 diagn\u00F3za, chybn\u00E1 diagn\u00F3za a vytv\u00E1\u0159en\u00ED fale\u0161n\u00E9ho pocitu bezpe\u010D\u00ED jsou potenci\u00E1ln\u00ED ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky screeningu.Screening znamen\u00E1 proces t\u0159\u00EDd\u011Bn\u00ED a m\u00E1 3 odli\u0161n\u00E9 v\u00FDznamy: vy\u0161et\u0159en\u00ED vybran\u00E9 populace na ur\u010Dit\u00E9 l\u00E1tky nebo symptomy (p\u0159. \u017Eeny nad 40 mamografick\u00FD screening) individu\u00E1ln\u00ED mnoho\u010Detn\u00E9 vy\u0161et\u0159en\u00ED za \u00FA\u010Delem identifikovat choroboplodn\u00ED koncentraci nebo roz\u0161\u00ED\u0159en\u00ED nemoci \u010Di posti\u017Een\u00ED (drogov\u00FD screening) p\u0159edb\u011B\u017En\u00E9 vy\u0161et\u0159en\u00ED za \u00FA\u010Delem indikace pro plnohodnotnou diagnostiku (nap\u0159. ment\u00E1ln\u00ED nebo psychick\u00E1 posti\u017Een\u00ED)Benefit p\u0159edb\u011B\u017En\u00E9ho vy\u0161et\u0159en\u00ED spo\u010D\u00EDv\u00E1 p\u0159edev\u0161\u00EDm v tom, \u017Ee: klientovi/pacientovi se sn\u00E1ze dostane \u010Dasn\u00E1 terapeutick\u00E1 p\u00E9\u010De (p\u0159edev\u0161\u00EDm u p\u0159ed\u0161koln\u00EDch d\u011Bt\u00ED) - to m\u00E1 velk\u00FD v\u00FDznam p\u0159edev\u0161\u00EDm v p\u0159\u00EDpad\u011B podez\u0159en\u00ED na PAS, proto\u017Ee odborn\u00E1 diagnostika je \u0161patn\u011B dostupn\u00E1 a n\u011Bkte\u0159\u00ED klienti \u010Dekaj\u00ED na vy\u0161et\u0159en\u00ED i d\u00E9le ne\u017E rok a tato doba m\u016F\u017Ee u d\u011Bt\u00ED do 6 let z\u00E1sadn\u011B rozhodnout o dal\u0161\u00EDm v\u00FDvoji posti\u017Een\u00ED, je-li v\u010Dasn\u011B podchycena. p\u0159i prov\u00E1d\u011Bn\u00ED screeningov\u00E9ho testu b\u00FDvaj\u00ED kladeny men\u0161\u00ED n\u00E1roky na administr\u00E1tora - typicky ve \u0161kolsk\u00E9 poradensk\u00E9 p\u00E9\u010Di jsou n\u011Bkter\u00E9 screeningov\u00E9 testy administrov\u00E1ny speci\u00E1ln\u00EDm pedagogem nebo psychologem."@cs . . . "screening"@cs . . . "Screening je v l\u00E9ka\u0159stv\u00ED vy\u0161et\u0159ov\u00E1n\u00ED p\u0159edem definovan\u00E9 skupiny lid\u00ED za \u00FA\u010Delem vyhled\u00E1v\u00E1n\u00ED chorob v jejich \u010Dasn\u00FDch st\u00E1di\u00EDch, kdy pacient je\u0161t\u011B nem\u00E1 pot\u00ED\u017Ee a p\u0159\u00EDznaky nebo jsou tyto p\u0159\u00EDznaky spolehliv\u011B identifikovateln\u00E9 jen \u010Dasov\u011B nebo finan\u010Dn\u011B n\u00E1kladn\u00FDm procesem. C\u00EDlem screeningu je brzk\u00E9 rozezn\u00E1n\u00ED nemoci v nad\u011Bji, \u017Ee se v\u010Dasn\u00FDm z\u00E1sahem a p\u00E9\u010D\u00ED poda\u0159\u00ED sn\u00ED\u017Eit \u00FAmrtnost a str\u00E1d\u00E1n\u00ED. I kdy\u017E m\u016F\u017Ee screening v\u00E9st k \u010Dasn\u011Bj\u0161\u00ED diagn\u00F3ze, ukazuje se, \u017Ee ne poka\u017Ed\u00E9 testy prosp\u011Bj\u00ED testovan\u00E9 osob\u011B."@cs .